Assignee
APT THERAPEUTICS INC
US·3 granted patents·2 pending applications·25 citations·filing 2003–2015
Top patents by PatentIndex Score
5 records- 0183US7247300B1Therapeutic use of soluble CD39L3APT THERAPEUTICS INC·Filed 2003·Granted Jul 24, 2007·16 cites·15 claims
- 0280US7390485B2Design and therapeutic use of adpase enhanced apyrasesAPT THERAPEUTICS INC·Filed 2005·Granted Jun 24, 2008·8 cites·28 claims
- 0374US8021866B2Therapeutic use of ADPase enhanced apyrasesAPT THERAPEUTICS INC·Filed 2008·Granted Sep 20, 2011·1 cites·10 claims
- 0435US2015265685A1Apyrase therapy for fibroproliferative disorders, pulmonary hypertension, and heart failureAPT THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 0534US2017333532A1Adp'ase-enhanced apyrase therapy for wounds, microbial infection, sepsis, and heterotopic ossificationAPT THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when APT THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →